Darnitsa Launched a Drug for the Nervous System – Alphacholine02 July 2020
Darnitsa launched a new drug for the treatment of diseases of the central nervous system – Alphacholine.
Alphacholine has a positive effect on the memory function and cognitive abilities, as well as indicators of the emotional state and behavior, the deterioration of which was due to the development of involutional pathology of the brain.
The drug improves cerebral blood flow, enhances metabolic processes in the brain, activates the structures of the reticular formation of the brain and helps to restore consciousness in a traumatic brain injury.
The drug is available in the form of the solution for injections with the dosage of 1,000 mg per 4ml of one ampoule, with 5 ampoules per pack.
The drug is available on prescription.
Marketing authorization of the solution for injections UA/17917/02/01.
The information is intended solely for medical and pharmaceutical professionals for professional use. The information is presented in a short form. For full information on the drug and possible side effects, see the instructions for medical use. The web-site is a specialized publication intended for medical and pharmaceutical professionals. You should consult a doctor before using this medicine. Self-medication can be dangerous to your health.